Molecular Research on Prostate Cancer
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 May 2024 | Viewed by 528
Special Issue Editor
Interests: prostate cancer; genomics; transcriptome; tumor biomarkers; tumorigenesis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Prostate cancer represents a significant global health challenge, with a demand for improved patient outcomes. Despite treatment strategy advancements, the molecular complexity of this disease remains a daunting hurdle. Understanding the molecular mechanism driving prostate cancer initiation, progression and therapeutic resistance is pivotal for developing precise and effective interventions.
This Special Issue aims to consolidate the latest findings and perspectives on the molecular landscape of prostate cancer, genomic alterations, epigenetic modifications, signaling pathways and novel biomarkers. We aim to foster a collaborative platform for researchers to contribute transformative insights that can shape the future of prostate cancer management and provide a comprehensive overview of the latest breakthroughs in the field. Authors are invited to contribute research articles elucidating the molecular intricacies underlying prostate cancer, fostering a deeper comprehension that can shape relevant targeted therapies and precision medicine.
Dr. Yaser Gamallat
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer
- molecular biology
- genomics
- biomarkers
- signaling pathways
- precision medicine
- treatment resistance
- epigenetics
- therapeutic targets
